X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (31066) 31066
Magazine Article (212) 212
Book / eBook (80) 80
Book Chapter (48) 48
Web Resource (34) 34
Conference Proceeding (33) 33
Dissertation (28) 28
Publication (28) 28
Book Review (20) 20
Reference (12) 12
Journal / eJournal (4) 4
Paper (3) 3
Government Document (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27109) 27109
fibrinolytic agents - therapeutic use (18118) 18118
male (13167) 13167
female (11820) 11820
middle aged (8729) 8729
aged (8299) 8299
fibrinolytic agents - administration & dosage (7209) 7209
treatment outcome (6369) 6369
animals (5697) 5697
adult (5050) 5050
fibrinolytic agents - adverse effects (4700) 4700
peripheral vascular disease (4613) 4613
thrombolytic therapy (4474) 4474
fibrinolytic agents - pharmacology (4440) 4440
tissue plasminogen activator - therapeutic use (4048) 4048
risk factors (3973) 3973
time factors (3944) 3944
stroke (3598) 3598
cardiac & cardiovascular systems (3541) 3541
thrombolysis (3337) 3337
myocardial infarction - drug therapy (3292) 3292
stroke - drug therapy (3251) 3251
aged, 80 and over (3240) 3240
anticoagulants - therapeutic use (3085) 3085
clinical neurology (3013) 3013
hematology (2714) 2714
thrombolytic therapy - methods (2589) 2589
thrombosis (2468) 2468
retrospective studies (2450) 2450
tissue plasminogen activator - administration & dosage (2368) 2368
therapy (2354) 2354
medicine, general & internal (2139) 2139
surgery (2103) 2103
heparin - therapeutic use (2042) 2042
platelet aggregation inhibitors - therapeutic use (2009) 2009
thrombosis - drug therapy (2002) 2002
fibrinolytic agents (1960) 1960
acute disease (1795) 1795
fibrinolysis (1781) 1781
prospective studies (1781) 1781
rats (1758) 1758
brain ischemia - drug therapy (1702) 1702
mortality (1699) 1699
anticoagulants (1688) 1688
aspirin - therapeutic use (1686) 1686
pharmacology & pharmacy (1667) 1667
care and treatment (1640) 1640
tissue plasminogen activator (1594) 1594
management (1580) 1580
drug therapy, combination (1575) 1575
follow-up studies (1562) 1562
acute ischemic-stroke (1477) 1477
risk (1467) 1467
aspirin (1461) 1461
heparin (1461) 1461
streptokinase - therapeutic use (1426) 1426
prognosis (1398) 1398
prevention (1392) 1392
abridged index medicus (1386) 1386
myocardial infarction - therapy (1374) 1374
tissue-plasminogen activator (1359) 1359
hemorrhage - chemically induced (1325) 1325
thrombosis - prevention & control (1295) 1295
risk assessment (1275) 1275
neurosciences (1254) 1254
acute myocardial-infarction (1242) 1242
dose-response relationship, drug (1241) 1241
thrombolytic therapy - adverse effects (1235) 1235
clinical trials as topic (1234) 1234
randomized controlled trials as topic (1232) 1232
trial (1229) 1229
electrocardiography (1227) 1227
ischemia (1212) 1212
drug therapy (1197) 1197
pulmonary embolism - drug therapy (1188) 1188
recombinant proteins - therapeutic use (1143) 1143
tissue plasminogen activator - adverse effects (1112) 1112
analysis (1109) 1109
recurrence (1105) 1105
alteplase (1101) 1101
stroke - etiology (1074) 1074
anticoagulants - administration & dosage (1063) 1063
blood coagulation - drug effects (1053) 1053
adolescent (1049) 1049
medicine & public health (1036) 1036
rabbits (1032) 1032
infusions, intravenous (1025) 1025
disease models, animal (1023) 1023
myocardial infarction - mortality (994) 994
tomography, x-ray computed (991) 991
thrombosis - etiology (990) 990
platelet aggregation - drug effects (986) 986
thromboembolism (982) 982
neurology (980) 980
anticoagulants - adverse effects (967) 967
molecular-weight heparin (961) 961
stroke - prevention & control (958) 958
stroke - therapy (930) 930
mice (922) 922
health aspects (911) 911
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (62) 62
Online Resources - Online (31) 31
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Gerstein Science - Periodical Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
UofT at Mississauga - Stacks (2) 2
Gerstein Science - Theses (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Mt Sinai Hospital - Online (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UTL at Downsview - May be requested (1) 1
University Archives - Archives (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (27286) 27286
German (1184) 1184
French (905) 905
Russian (695) 695
Spanish (523) 523
Japanese (470) 470
Italian (428) 428
Chinese (282) 282
Polish (195) 195
Portuguese (131) 131
Danish (99) 99
Norwegian (80) 80
Dutch (72) 72
Swedish (71) 71
Hungarian (65) 65
Finnish (45) 45
Czech (41) 41
Turkish (34) 34
Romanian (28) 28
Bulgarian (23) 23
Ukrainian (23) 23
Hebrew (22) 22
Serbian (16) 16
Korean (13) 13
Croatian (12) 12
Lithuanian (9) 9
Slovak (7) 7
Icelandic (2) 2
Afrikaans (1) 1
Bosnian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current medicinal chemistry, ISSN 0929-8673, 07/2007, Volume 14, Issue 17, pp. 1829 - 1852
Journal Article
Current medicinal chemistry, ISSN 0929-8673, 08/2015, Volume 22, Issue 24, pp. 2819 - 2857
Heterocyclic N-oxides have emerged as potent compounds with anticancer, antibacterial, antihypertensive, antiparasitic, anti-HIV, anti-inflammatory,... 
Antichagasic agents | Heterocyclic N-oxides | Bioisosteres | Factor xa inhibitors | Antimalarials | Hypoxia | Nitric oxide mimics | Coagulation cascade direct thrombin inhibitors | hypoxia | TRANSITION-METAL CATALYSIS | BETA-AMINOESTER CLASS | CHEMISTRY, MEDICINAL | ACTIVATED PROTEIN-KINASE | antichagasic agents | K-ATP CHANNELS | BIOCHEMISTRY & MOLECULAR BIOLOGY | antimalarials | HUMAN-LEUKOCYTE ELASTASE | coagulation cascade direct thrombin inhibitors | CARBON BOND FORMATION | 1,3-DIOXIDE CORE SCAFFOLDS | HIV-1 ENTRY INHIBITORS | PHARMACOLOGY & PHARMACY | bioisosteres | factor Xa inhibitors | LONG-TERM POTENTIATION | FACTOR XA INHIBITOR | nitric oxide mimics | Anti-HIV Agents - pharmacology | Neuroprotective Agents - therapeutic use | Antihypertensive Agents - pharmacology | Humans | Antineoplastic Agents - therapeutic use | Herbicides - pharmacology | Antihypertensive Agents - therapeutic use | Anti-Bacterial Agents - therapeutic use | Fibrinolytic Agents - pharmacology | Cyclic N-Oxides - therapeutic use | Animals | Neuroprotective Agents - pharmacology | Cyclic N-Oxides - pharmacology | Protein Kinase Inhibitors - therapeutic use | Fibrinolytic Agents - therapeutic use | Anti-HIV Agents - therapeutic use | Anti-Bacterial Agents - pharmacology | Antineoplastic Agents - pharmacology | Protein Kinase Inhibitors - pharmacology
Journal Article
Trends in biotechnology (Regular ed.), ISSN 0167-7799, 2004, Volume 22, Issue 3, pp. 142 - 146
...-adhesive agents to pathogens, making them useful for treating many diseases and as therapeutic and probiotic agents... 
IN-VITRO | ITURIN-A | ANTIBIOTICS | ACTIVATION | BACILLUS-SUBTILIS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | ENHANCEMENT | MANNOSYLERYTHRITOL LIPIDS | BIOSURFACTANTS | GENE TRANSFECTION | PLASMINOGEN | Fibrinolysis - drug effects | Surface-Active Agents - therapeutic use | Antibiotics, Antineoplastic - pharmacology | Gram-Positive Bacteria - drug effects | Anti-Infective Agents - pharmacology | Humans | Peptides, Cyclic - pharmacology | Peptides, Cyclic - chemistry | Antifungal Agents - therapeutic use | Anti-Bacterial Agents - therapeutic use | Anti-Infective Agents - chemistry | Fibrinolytic Agents - therapeutic use | Glycolipids - chemistry | Bacterial Adhesion - drug effects | Antifungal Agents - pharmacology | Antiviral Agents - pharmacology | Peptides - chemistry | Antiviral Agents - therapeutic use | Glycolipids - pharmacology | Anti-Infective Agents - therapeutic use | Peptides - pharmacology | Surface-Active Agents - pharmacology | Fibrinolytic Agents - pharmacology | Antibiotics, Antineoplastic - therapeutic use | Cell Differentiation - drug effects | Lipoproteins - pharmacology | Peptides, Cyclic - therapeutic use | Anti-Bacterial Agents - pharmacology | Surface-Active Agents - chemistry | Lipopeptides | Peptides - therapeutic use | Salmonella | Signal transduction | Probiotics | E coli | Herpes viruses | Antimicrobial agents | Lipids | Genetic engineering | Drug resistance | Surfactants | Bacteriology
Journal Article
Gastrointestinal endoscopy, ISSN 0016-5107, 2016, Volume 83, Issue 1, pp. 3 - 16
Journal Article
Mini reviews in medicinal chemistry, ISSN 1389-5575, 2014, Volume 14, Issue 4, pp. 355 - 369
In the present article synthesis and medicinal applications of [1, 2, 4] oxadiazoles are reviewed. The oxadiazoles have a wide range of applications such as... 
Heterocycles | Anti-tumor agents | Synthetic methods | Anti-inflammatory | [1,2,4] oxadiazoles | Anaesthetic angent | One pot synthesis | CONVENIENT SYNTHESIS | CHEMISTRY, MEDICINAL | NONQUATERNARY CHOLINESTERASE REACTIVATORS | ONE-POT SYNTHESIS | 2,5-DISUBSTITUTED 1,3,4-OXADIAZOLES | MICROWAVE IRRADIATION | ACETYLCHOLINESTERASE INVITRO | anti-tumor agents | one pot synthesis | SOLVENT-FREE | heterocycles | anti-inflammatory | ANTIPROTOZOAL ACTIVITY | synthetic methods | 1,2,4-OXADIAZOLE DERIVATIVES | PHARMACOLOGICAL-PROPERTIES | Fibrinolytic Agents - chemistry | Vasodilator Agents - therapeutic use | Apoptosis - drug effects | Antineoplastic Agents - chemical synthesis | Anesthetics - pharmacology | Hypersensitivity - drug therapy | Antineoplastic Agents - toxicity | Platelet Aggregation Inhibitors - chemical synthesis | Oxadiazoles - pharmacology | Fibrinolytic Agents - therapeutic use | Anesthetics - chemical synthesis | Platelet Aggregation Inhibitors - pharmacology | Vasodilator Agents - chemical synthesis | Fibrinolytic Agents - chemical synthesis | Blood Platelets - drug effects | Oxadiazoles - chemistry | Venous Thrombosis - drug therapy | Anesthetics - chemistry | Anti-Inflammatory Agents - pharmacology | Antineoplastic Agents - chemistry | Oxadiazoles - therapeutic use | Animals | Anti-Inflammatory Agents - chemistry | Platelet Aggregation Inhibitors - chemistry | Vasodilator Agents - chemistry | Anti-Inflammatory Agents - chemical synthesis
Journal Article
Progress in chemical fibrinolysis and thrombolysis, ISSN 0361-0233, 1975
Journal
Marine drugs, ISSN 1660-3397, 2011, Volume 9, Issue 10, pp. 1761 - 1805
Sea cucumbers, belonging to the class Holothuroidea, are marine invertebrates, habitually found in the benthic areas and deep seas across the world. They have... 
Functional peptides | Biological activities | Sea cucumber bioactives | Triterpene glycosides | Glycosaminoglycan | Antioxidant nutrients | Medicinal health functions | sea cucumber bioactives | FUCOSE BRANCHES | CHEMISTRY, MEDICINAL | functional peptides | ACE INHIBITORY PEPTIDE | FUCOSYLATED CHONDROITIN SULFATE | CYTOTOXIC TRITERPENE GLYCOSIDES | HOT-WATER EXTRACTS | STICHOPUS-JAPONICUS | POLYSACCHARIDE ACCOUNT | antioxidant nutrients | biological activities | IN-VITRO | medicinal health functions | POLYUNSATURATED FATTY-ACIDS | ANTICOAGULANT ACTIVITIES | triterpene glycosides | glycosaminoglycan | Sea Cucumbers - chemistry | Anti-Infective Agents - isolation & purification | Nutritive Value | Anti-Infective Agents - therapeutic use | Anticoagulants - therapeutic use | Fisheries | Stichopus - metabolism | Antineoplastic Agents - therapeutic use | Antihypertensive Agents - therapeutic use | Fibrinolytic Agents - isolation & purification | Holothuria - chemistry | Stichopus - chemistry | Cucumaria - metabolism | Animals | Antihypertensive Agents - isolation & purification | Antineoplastic Agents - isolation & purification | Cucumaria - chemistry | Fibrinolytic Agents - therapeutic use | Holothuria - metabolism | Sea Cucumbers - metabolism | Angiogenesis Inhibitors - therapeutic use | Angiogenesis Inhibitors - isolation & purification | Seafood - analysis | Anticoagulants - isolation & purification
Journal Article
Journal Article